Barrington Research Maintains Outperform on HealthEquity, Maintains $125 Price Target

Benzinga · 1d ago
Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and maintains $125 price target.